封面
市場調查報告書
商品編碼
1418451

臨床試驗設備和輔助解決方案市場報告:2030 年趨勢、預測和競爭分析

Clinical Trial Equipment & Ancillary Solutions Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

臨床試驗設備及相關解決方案的趨勢與預測

預計2024年至2030年,全球臨床試驗設備和輔助解決方案市場將以8.2%的複合年成長率成長。該市場的主要促進因素是製藥和醫療保健行業的快速成長以及研發投資的增加。全球臨床試驗設備及輔助解決方案市場前景廣闊,一期、二期、三期市場機會龐大。

臨床試驗設備與輔助解決方案市場洞察

Lucintel 預測,由於新興市場規則和法規的變化,供應/物流將在預測期內實現最高成長。

在這個市場中,由於對有效供應鏈和物流的需求不斷增加,第三階段可能仍然是最大的細分市場。

由於患者數量不斷增加,預計亞太地區在預測期內將出現最高成長。

常問問題

Q1.市場成長預測如何?

A1. 2024年至2030年,全球臨床試驗設備和輔助解決方案市場預計將以8.2%的複合年成長率成長。

Q2.影響市場成長的主要促進因素有哪些?

A2. 該市場的主要促進因素是醫藥保健產業的快速成長和研發投入的增加。

Q3.市場的主要細分市場有哪些?

A3. 臨床試驗設備及配套解決方案市場未來性廣闊,一、二、三期市場存在機會。

Q4.市場上主要企業有哪些?

A4. 主要臨床試驗設備及相關解決方案公司如下。

  • Ancillare
  • Imperial Crs
  • Woodley Equipment
  • Thermo Fisher Scientific
  • Parexel International
  • Emsere
  • Quipment Sas
  • Irm
  • Marken
  • Myonex

Q5.未來最大的細分市場是什麼?

A5.Lucintel 預計,由於新興市場規則和法規的變化,供應/物流將在預測期內達到最高成長。

Q6. 未來五年預計哪個地區將成為最大的市場?

由於患者數量增加,預計 A6.APAC 在預測期內將出現最高成長。

Q7. 可以客製化報告嗎?

A7. 是的,Lucintel 提供 10% 的客製化服務,無需額外費用。

目錄

第1章執行摘要

第2章全球臨床試驗設備與輔助解決方案市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球臨床試驗設備及輔助解決方案市場趨勢(2018-2023)與預測(2024-2030)
  • 按產品分類的全球臨床試驗設備和輔助解決方案市場
    • 採購
    • 出租
    • 供應/物流
    • 服務
    • 其他
  • 按階段分類的全球臨床試驗設備和輔助解決方案市場
    • 第一階段
    • 第二階段
    • 第三階段

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球臨床試驗設備及輔助解決方案市場(按地區)
  • 北美臨床試驗設備及配套解決方案市場
  • 歐洲臨床試驗設備及輔助解決方案市場
  • 亞太臨床試驗設備與輔助解決方案市場
  • 其他地區臨床試驗設備及配對解決方案市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球臨床試驗設備和輔助解決方案市場成長機會(按產品)
    • 全球臨床試驗設備和輔助解決方案市場成長機會(按階段)
    • 全球臨床試驗設備和輔助解決方案市場成長機會(按地區)
  • 全球臨床試驗設備和輔助解決方案市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球臨床試驗設備和輔助解決方案市場的產能
    • 全球臨床試驗設備和輔助解決方案市場的併購和合資企業
    • 認證和許可

第7章主要企業概況

  • Ancillare
  • Imperial CRS
  • Woodley Equipment
  • Thermo Fisher Scientific
  • PAREXEL International
  • Emsere
  • Quipment SAS
  • IRM
  • Marken
  • Myonex
簡介目錄

Clinical Trial Equipment & Ancillary Solutions Trends and Forecast

The future of the global clinical trial equipment & ancillary solutions market looks promising with opportunities in the phase I, phase II, phase III markets. The global clinical trial equipment & ancillary solutions market is expected to grow with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rapid growth in the sectors of medicines and healthcare and rising r&d investments.

A more than 150-page report is developed to help in your business decisions.

Clinical Trial Equipment & Ancillary Solutions by Segment

The study includes a forecast for the global clinical trial equipment & ancillary solutions by product, phase, and region.

Clinical Trial Equipment & Ancillary Solutions Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Sourcing
  • Rental
  • Supply/Logistics
  • Service
  • Others

Clinical Trial Equipment & Ancillary Solutions Market by Phase [Shipment Analysis by Value from 2018 to 2030]:

  • Phase I
  • Phase III
  • Phase III

Clinical Trial Equipment & Ancillary Solutions Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Clinical Trial Equipment & Ancillary Solutions Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clinical trial equipment & ancillary solutions companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clinical trial equipment & ancillary solutions companies profiled in this report include-

  • Ancillare
  • Imperial CRS
  • Woodley Equipment
  • Thermo Fisher Scientific
  • Parexel International
  • Emsere
  • Quipment SAS
  • IRM
  • Marken
  • Myonex

Clinical Trial Equipment & Ancillary Solutions Market Insights

Lucintel forecasts that supply/logistics is expected to witness highest growth over the forecast period due to changes in rules & regulations in emerging markets.

Within this market, phase iii will remain the largest segment due to rise in the demand for effective supply chain and logistics.

APAC is expected to witness highest growth over the forecast period due to growing patient population.

Features of the Global Clinical Trial Equipment & Ancillary Solutions Market

Market Size Estimates: Clinical trial equipment & ancillary solutions market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Clinical trial equipment & ancillary solutions market size by product, phase, and region in terms of value ($B).

Regional Analysis: Clinical trial equipment & ancillary solutions market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, phase, and regions for the clinical trial equipment & ancillary solutions market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clinical trial equipment & ancillary solutions market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for clinical trial equipment & ancillary solutions market?

Answer: The global clinical trial equipment & ancillary solutions market is expected to grow with a CAGR of 8.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the clinical trial equipment & ancillary solutions market?

Answer: The major drivers for this market are rapid growth in the sectors of medicines and healthcare and rising r&d investments.

Q3. What are the major segments for clinical trial equipment & ancillary solutions market?

Answer: The future of the clinical trial equipment & ancillary solutions market looks promising with opportunities in the phase I, phase II, phase III markets.

Q4. Who are the key clinical trial equipment & ancillary solutions market companies?

Answer: Some of the key clinical trial equipment & ancillary solutions companies are as follows.

  • Ancillare
  • Imperial Crs
  • Woodley Equipment
  • Thermo Fisher Scientific
  • Parexel International
  • Emsere
  • Quipment Sas
  • Irm
  • Marken
  • Myonex

Q5. Which clinical trial equipment & ancillary solutions market segment will be the largest in future?

Answer: Lucintel forecasts that supply/logistics is expected to witness highest growth over the forecast period due to changes in rules & regulations in emerging markets.

Q6. In clinical trial equipment & ancillary solutions market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing patient population.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the clinical trial equipment & ancillary solutions market by product (sourcing, rental, supply/logistics, service, and others), phase (phase i, phase ii, and phase iii), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Clinical Trial Equipment & Ancillary Solutions Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Clinical Trial Equipment & Ancillary Solutions Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Clinical Trial Equipment & Ancillary Solutions Market by Product
    • 3.3.1: Sourcing
    • 3.3.2: Rental
    • 3.3.3: Supply/Logistics
    • 3.3.4: Service
    • 3.3.5: Others
  • 3.4: Global Clinical Trial Equipment & Ancillary Solutions Market by Phase
    • 3.4.1: Phase I
    • 3.4.2: Phase II
    • 3.4.3: Phase III

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Clinical Trial Equipment & Ancillary Solutions Market by Region
  • 4.2: North American Clinical Trial Equipment & Ancillary Solutions Market
    • 4.2.2: North American Clinical Trial Equipment & Ancillary Solutions Market by Phase: Phase I, Phase II, and Phase III
  • 4.3: European Clinical Trial Equipment & Ancillary Solutions Market
    • 4.3.1: European Clinical Trial Equipment & Ancillary Solutions Market by Product: Sourcing, Rental, Supply/Logistics, Service, and Others
    • 4.3.2: European Clinical Trial Equipment & Ancillary Solutions Market by Phase: Phase I, Phase II, and Phase III
  • 4.4: APAC Clinical Trial Equipment & Ancillary Solutions Market
    • 4.4.1: APAC Clinical Trial Equipment & Ancillary Solutions Market by Product: Sourcing, Rental, Supply/Logistics, Service, and Others
    • 4.4.2: APAC Clinical Trial Equipment & Ancillary Solutions Market by Phase: Phase I, Phase II, and Phase III
  • 4.5: ROW Clinical Trial Equipment & Ancillary Solutions Market
    • 4.5.1: ROW Clinical Trial Equipment & Ancillary Solutions Market by Product: Sourcing, Rental, Supply/Logistics, Service, and Others
    • 4.5.2: ROW Clinical Trial Equipment & Ancillary Solutions Market by Phase: Phase I, Phase II, and Phase III

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Clinical Trial Equipment & Ancillary Solutions Market by Product
    • 6.1.2: Growth Opportunities for the Global Clinical Trial Equipment & Ancillary Solutions Market by Phase
    • 6.1.3: Growth Opportunities for the Global Clinical Trial Equipment & Ancillary Solutions Market by Region
  • 6.2: Emerging Trends in the Global Clinical Trial Equipment & Ancillary Solutions Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Clinical Trial Equipment & Ancillary Solutions Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clinical Trial Equipment & Ancillary Solutions Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Ancillare
  • 7.2: Imperial CRS
  • 7.3: Woodley Equipment
  • 7.4: Thermo Fisher Scientific
  • 7.5: PAREXEL International
  • 7.6: Emsere
  • 7.7: Quipment SAS
  • 7.8: IRM
  • 7.9: Marken
  • 7.10: Myonex